NVS, LLY: Novartis, Eli Lilly Complete Animal-Health Division Sale

Novartis (NVS) has sold its animal health division to Eli Lilly (LLY). The deal is valued north of $5 billion. More 

VNDA, NVS: Vanda Pharmaceuticals, Novartis Resolve Fanapt Dispute

Vanda Pharmaceuticals and Novartis have reached an agreement in their Fanapt dispute that will return rights to the drug to the former. More 

10 Biggest Mergers and Acquisitions of 2014

Mergers and acquisitions had a big year in 2014. Here's a look back at the ten biggest M&A deals of 2014. More 

Novartis Stock: RX for Your Portfolio

Novartis is a global drug giant positioned to profit from Obamacare, demographic trends and exciting new drugs in the pipeline. With a huge market cap and several best-selling treatments in its portfolio, Novartis is a long-term bet on the continuing expansion of the health care sector. More 

3 Best ETFs for International Investing

My picks for the 3 best ETFs for international investing are all highly diversified to reduce the risk of investing in foreign markets More 

Hottest Healthcare Stocks Now – AVNR BIIB ARIA ACHN

Healthcare stocks advanced 0.9% on Wall Street on Tuesday morning. More 

Hottest Healthcare Stocks Now – PDLI CVD MCK LLY

Healthcare stocks rose 0.6% on Wall Street on Friday. More